
In Vitro Diagnostics Market By Product and Services (Reagents and Kits, Instruments, Software and Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Di
Description
In Vitro Diagnostics Market By Product and Services (Reagents and Kits, Instruments, Software and Services), By Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, Others), By End User (Standalone Laboratories, Hospitals, Academic and Medical Schools, Point of Care, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
The in vitro diagnostics market was valued at $92.5 billion in 2022 and is estimated to reach $138.4 billion by 2032, exhibiting a CAGR of 4.1% from 2023 to 2032. In vitro diagnostics (IVDs) are tests that detect diseases, conditions, and infections. In vitro means these tests are typically conducted in test tubes and similar equipment, as opposed to in vivo tests, which are conducted in the body itself. In vitro diagnostics (IVD) includes a wide range of tools and techniques, including reagents, instruments, software, and services utilized for the examination of specimens such as blood, urine, stool, tissues, and various human body fluids. These diagnostic tools are essential for detecting diseases, conditions, and infections. IVD tests are conducted in various settings, including standalone laboratories, hospital-based facilities, and point of care centers.
In addition, in vitro diagnostic techniques encompass a broad array of methodologies, including clinical chemistry, tissue diagnostics, immunodiagnostics, hematology, and more. For instance, a thyroid function test involves the collection of blood from a patient, which is then analyzed to determine the level of thyroid-stimulating hormone (TSH) in the bloodstream. This test serves as a critical tool in assessing thyroid function. Furthermore, techniques such as polymerase chain reaction (PCR) are employed to identify the presence of infectious diseases such as HIV, hepatitis, and various others. The in vitro diagnostics market growth is significantly driven by increase in the prevalence of chronic diseases such as cardiovascular disorders, cancer, and infectious diseases, surge in awareness about importance of early disease diagnosis, and increase in new test launches, thus fueling the demand for IVD tests for early detection, monitoring, and management. For instance, according to American Cancer Society (ACS), about 1.9 million new cancer cases are expected to be diagnosed in the U.S. in 2023. Thus, rise in prevalence of chronic diseases drives the demand for in vitro diagnostic tests.
In addition, surge in awareness about early disease diagnosis among the general population has increased the demand for in vitro diagnostics. Awareness campaigns, educational seminars, and training programs emphasize the importance of early disease diagnosis. For instance, F. Hoffmann-La Roche Ltd., supports local community partners to run screening programs and counselling programs for diseases such as cancers, hepatitis, tuberculosis, HIV, HPV, and cardiovascular disease. Moreover, ongoing innovations in IVD products, service designs, and technology have prompted doctors and researchers to transition their emphasis away from conventional diagnostic approaches toward personalized medicine. This shift reflects a growing recognition of the benefits of tailoring medical treatments and interventions to individual patient needs and characteristics, which support the market growth.
However, lack of skilled laboratory technicians is anticipated to hinder the market growth during the forecast period. However, rise in the number of diagnostic testing and technological advancements in DNA sequencing are expected to create lucrative opportunities for the market growth during the forecast period.
The in vitro diagnostics market is segmented into product & services, technique, application, end user, and region. By product & services, the market is categorized into reagents & kits, instruments, and software & services.
By technique, the market is divided into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and others. By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and others. By end user, the market is classified into standalone laboratories, hospitals, academic and medical schools, point of care, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global in vitro diagnostics market are Freenome Holdings, Inc., Invitae Corporation, Natera, Inc., Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., InterVenn Biosciences, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific, Inc. Key players operating in the market have adopted product launch, acquisition, partnership, product approval, and expansion as key strategies to expand their market share and product portfolio.
Key Benefits for Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the in vitro diagnostics market analysis from 2022 to 2032 to identify the prevailing in vitro diagnostics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the in vitro diagnostics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global in vitro diagnostics market trends, key players, market segments, application areas, and market growth strategies.
Additional company profiles with specific to client's interest
Additional country or region analysis- market size and forecast
Expanded list for Company Profiles
Historic market data
SWOT Analysis
Key Market Segments
By End User
Standalone Laboratories
Hospitals
Academic and Medical Schools
Point of Care
Others
By Product and Services
Reagents and Kits
Instruments
Software and Services
By Technique
Molecular Diagnostics
Tissue Diagnostics
Clinical Chemistry
Others
Immunodiagnostics
Hematology
By Application
Infectious Diseases
Cancer
Cardiac Diseases
Immune System Disorders
Nephrological Diseases
Gastrointestinal Diseases
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
InterVenn Biosciences
Agilent Technologies, Inc.
Illumina, Inc.
Thermo Fisher Scientific, Inc.
NeoGenomics Laboratories
Exact Sciences Corporation
Freenome Holdings, Inc.
Natera, Inc.
F. Hoffmann-La Roche Ltd.
Guardant Health
Invitae Corporation
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
Table of Contents
391 Pages
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Moderate bargaining power of suppliers
- 3.3.2. Moderate threat of new entrants
- 3.3.3. Moderate threat of substitutes
- 3.3.4. Moderate intensity of rivalry
- 3.3.5. High bargaining power of buyers
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Increase in prevalence of chronic and infectious diseases
- 3.4.1.2. Surge in awareness about early disease diagnosis and personalized medicine
- 3.4.1.3. Rise in number of diagnostic laboratories
- 3.4.2. Restraints
- 3.4.2.1. Stringent regulatory policies
- 3.4.3. Opportunities
- 3.4.3.1. Technological advancements in IVD
- CHAPTER 4: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Reagents and Kits
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Instruments
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Software and Services
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Immunodiagnostics
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Hematology
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- 5.4. Molecular Diagnostics
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
- 5.5. Tissue Diagnostics
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country
- 5.6. Clinical Chemistry
- 5.6.1. Key market trends, growth factors and opportunities
- 5.6.2. Market size and forecast, by region
- 5.6.3. Market share analysis by country
- 5.7. Others
- 5.7.1. Key market trends, growth factors and opportunities
- 5.7.2. Market size and forecast, by region
- 5.7.3. Market share analysis by country
- CHAPTER 6: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Infectious Diseases
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Cancer
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Cardiac Diseases
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- 6.5. Immune System Disorders
- 6.5.1. Key market trends, growth factors and opportunities
- 6.5.2. Market size and forecast, by region
- 6.5.3. Market share analysis by country
- 6.6. Nephrological Diseases
- 6.6.1. Key market trends, growth factors and opportunities
- 6.6.2. Market size and forecast, by region
- 6.6.3. Market share analysis by country
- 6.7. Gastrointestinal Diseases
- 6.7.1. Key market trends, growth factors and opportunities
- 6.7.2. Market size and forecast, by region
- 6.7.3. Market share analysis by country
- 6.8. Others
- 6.8.1. Key market trends, growth factors and opportunities
- 6.8.2. Market size and forecast, by region
- 6.8.3. Market share analysis by country
- CHAPTER 7: IN VITRO DIAGNOSTICS MARKET, BY END USER
- 7.1. Overview
- 7.1.1. Market size and forecast
- 7.2. Standalone Laboratories
- 7.2.1. Key market trends, growth factors and opportunities
- 7.2.2. Market size and forecast, by region
- 7.2.3. Market share analysis by country
- 7.3. Hospitals
- 7.3.1. Key market trends, growth factors and opportunities
- 7.3.2. Market size and forecast, by region
- 7.3.3. Market share analysis by country
- 7.4. Academic and Medical Schools
- 7.4.1. Key market trends, growth factors and opportunities
- 7.4.2. Market size and forecast, by region
- 7.4.3. Market share analysis by country
- 7.5. Point of Care
- 7.5.1. Key market trends, growth factors and opportunities
- 7.5.2. Market size and forecast, by region
- 7.5.3. Market share analysis by country
- 7.6. Others
- 7.6.1. Key market trends, growth factors and opportunities
- 7.6.2. Market size and forecast, by region
- 7.6.3. Market share analysis by country
- CHAPTER 8: IN VITRO DIAGNOSTICS MARKET, BY REGION
- 8.1. Overview
- 8.1.1. Market size and forecast By Region
- 8.2. North America
- 8.2.1. Key market trends, growth factors and opportunities
- 8.2.2. Market size and forecast, by Product and Services
- 8.2.3. Market size and forecast, by Technique
- 8.2.4. Market size and forecast, by Application
- 8.2.5. Market size and forecast, by End User
- 8.2.6. Market size and forecast, by country
- 8.2.6.1. U.S.
- 8.2.6.1.1. Market size and forecast, by Product and Services
- 8.2.6.1.2. Market size and forecast, by Technique
- 8.2.6.1.3. Market size and forecast, by Application
- 8.2.6.1.4. Market size and forecast, by End User
- 8.2.6.2. Canada
- 8.2.6.2.1. Market size and forecast, by Product and Services
- 8.2.6.2.2. Market size and forecast, by Technique
- 8.2.6.2.3. Market size and forecast, by Application
- 8.2.6.2.4. Market size and forecast, by End User
- 8.2.6.3. Mexico
- 8.2.6.3.1. Market size and forecast, by Product and Services
- 8.2.6.3.2. Market size and forecast, by Technique
- 8.2.6.3.3. Market size and forecast, by Application
- 8.2.6.3.4. Market size and forecast, by End User
- 8.3. Europe
- 8.3.1. Key market trends, growth factors and opportunities
- 8.3.2. Market size and forecast, by Product and Services
- 8.3.3. Market size and forecast, by Technique
- 8.3.4. Market size and forecast, by Application
- 8.3.5. Market size and forecast, by End User
- 8.3.6. Market size and forecast, by country
- 8.3.6.1. Germany
- 8.3.6.1.1. Market size and forecast, by Product and Services
- 8.3.6.1.2. Market size and forecast, by Technique
- 8.3.6.1.3. Market size and forecast, by Application
- 8.3.6.1.4. Market size and forecast, by End User
- 8.3.6.2. France
- 8.3.6.2.1. Market size and forecast, by Product and Services
- 8.3.6.2.2. Market size and forecast, by Technique
- 8.3.6.2.3. Market size and forecast, by Application
- 8.3.6.2.4. Market size and forecast, by End User
- 8.3.6.3. UK
- 8.3.6.3.1. Market size and forecast, by Product and Services
- 8.3.6.3.2. Market size and forecast, by Technique
- 8.3.6.3.3. Market size and forecast, by Application
- 8.3.6.3.4. Market size and forecast, by End User
- 8.3.6.4. Italy
- 8.3.6.4.1. Market size and forecast, by Product and Services
- 8.3.6.4.2. Market size and forecast, by Technique
- 8.3.6.4.3. Market size and forecast, by Application
- 8.3.6.4.4. Market size and forecast, by End User
- 8.3.6.5. Spain
- 8.3.6.5.1. Market size and forecast, by Product and Services
- 8.3.6.5.2. Market size and forecast, by Technique
- 8.3.6.5.3. Market size and forecast, by Application
- 8.3.6.5.4. Market size and forecast, by End User
- 8.3.6.6. Rest of Europe
- 8.3.6.6.1. Market size and forecast, by Product and Services
- 8.3.6.6.2. Market size and forecast, by Technique
- 8.3.6.6.3. Market size and forecast, by Application
- 8.3.6.6.4. Market size and forecast, by End User
- 8.4. Asia-Pacific
- 8.4.1. Key market trends, growth factors and opportunities
- 8.4.2. Market size and forecast, by Product and Services
- 8.4.3. Market size and forecast, by Technique
- 8.4.4. Market size and forecast, by Application
- 8.4.5. Market size and forecast, by End User
- 8.4.6. Market size and forecast, by country
- 8.4.6.1. Japan
- 8.4.6.1.1. Market size and forecast, by Product and Services
- 8.4.6.1.2. Market size and forecast, by Technique
- 8.4.6.1.3. Market size and forecast, by Application
- 8.4.6.1.4. Market size and forecast, by End User
- 8.4.6.2. China
- 8.4.6.2.1. Market size and forecast, by Product and Services
- 8.4.6.2.2. Market size and forecast, by Technique
- 8.4.6.2.3. Market size and forecast, by Application
- 8.4.6.2.4. Market size and forecast, by End User
- 8.4.6.3. India
- 8.4.6.3.1. Market size and forecast, by Product and Services
- 8.4.6.3.2. Market size and forecast, by Technique
- 8.4.6.3.3. Market size and forecast, by Application
- 8.4.6.3.4. Market size and forecast, by End User
- 8.4.6.4. Australia
- 8.4.6.4.1. Market size and forecast, by Product and Services
- 8.4.6.4.2. Market size and forecast, by Technique
- 8.4.6.4.3. Market size and forecast, by Application
- 8.4.6.4.4. Market size and forecast, by End User
- 8.4.6.5. South Korea
- 8.4.6.5.1. Market size and forecast, by Product and Services
- 8.4.6.5.2. Market size and forecast, by Technique
- 8.4.6.5.3. Market size and forecast, by Application
- 8.4.6.5.4. Market size and forecast, by End User
- 8.4.6.6. Rest of Asia-Pacific
- 8.4.6.6.1. Market size and forecast, by Product and Services
- 8.4.6.6.2. Market size and forecast, by Technique
- 8.4.6.6.3. Market size and forecast, by Application
- 8.4.6.6.4. Market size and forecast, by End User
- 8.5. LAMEA
- 8.5.1. Key market trends, growth factors and opportunities
- 8.5.2. Market size and forecast, by Product and Services
- 8.5.3. Market size and forecast, by Technique
- 8.5.4. Market size and forecast, by Application
- 8.5.5. Market size and forecast, by End User
- 8.5.6. Market size and forecast, by country
- 8.5.6.1. Brazil
- 8.5.6.1.1. Market size and forecast, by Product and Services
- 8.5.6.1.2. Market size and forecast, by Technique
- 8.5.6.1.3. Market size and forecast, by Application
- 8.5.6.1.4. Market size and forecast, by End User
- 8.5.6.2. Saudi Arabia
- 8.5.6.2.1. Market size and forecast, by Product and Services
- 8.5.6.2.2. Market size and forecast, by Technique
- 8.5.6.2.3. Market size and forecast, by Application
- 8.5.6.2.4. Market size and forecast, by End User
- 8.5.6.3. South Africa
- 8.5.6.3.1. Market size and forecast, by Product and Services
- 8.5.6.3.2. Market size and forecast, by Technique
- 8.5.6.3.3. Market size and forecast, by Application
- 8.5.6.3.4. Market size and forecast, by End User
- 8.5.6.4. Rest of LAMEA
- 8.5.6.4.1. Market size and forecast, by Product and Services
- 8.5.6.4.2. Market size and forecast, by Technique
- 8.5.6.4.3. Market size and forecast, by Application
- 8.5.6.4.4. Market size and forecast, by End User
- CHAPTER 9: COMPETITIVE LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product mapping of top 10 player
- 9.4. Competitive dashboard
- 9.5. Competitive heatmap
- 9.6. Top player positioning, 2022
- CHAPTER 10: COMPANY PROFILES
- 10.1. Freenome Holdings, Inc.
- 10.1.1. Company overview
- 10.1.2. Key executives
- 10.1.3. Company snapshot
- 10.1.4. Operating business segments
- 10.1.5. Product portfolio
- 10.1.6. Key strategic moves and developments
- 10.2. Natera, Inc.
- 10.2.1. Company overview
- 10.2.2. Key executives
- 10.2.3. Company snapshot
- 10.2.4. Operating business segments
- 10.2.5. Product portfolio
- 10.2.6. Business performance
- 10.2.7. Key strategic moves and developments
- 10.3. Agilent Technologies, Inc.
- 10.3.1. Company overview
- 10.3.2. Key executives
- 10.3.3. Company snapshot
- 10.3.4. Operating business segments
- 10.3.5. Product portfolio
- 10.3.6. Business performance
- 10.3.7. Key strategic moves and developments
- 10.4. Exact Sciences Corporation
- 10.4.1. Company overview
- 10.4.2. Key executives
- 10.4.3. Company snapshot
- 10.4.4. Operating business segments
- 10.4.5. Product portfolio
- 10.4.6. Business performance
- 10.4.7. Key strategic moves and developments
- 10.5. Illumina, Inc.
- 10.5.1. Company overview
- 10.5.2. Key executives
- 10.5.3. Company snapshot
- 10.5.4. Operating business segments
- 10.5.5. Product portfolio
- 10.5.6. Business performance
- 10.5.7. Key strategic moves and developments
- 10.6. F. Hoffmann-La Roche Ltd.
- 10.6.1. Company overview
- 10.6.2. Key executives
- 10.6.3. Company snapshot
- 10.6.4. Operating business segments
- 10.6.5. Product portfolio
- 10.6.6. Business performance
- 10.6.7. Key strategic moves and developments
- 10.7. Guardant Health
- 10.7.1. Company overview
- 10.7.2. Key executives
- 10.7.3. Company snapshot
- 10.7.4. Operating business segments
- 10.7.5. Product portfolio
- 10.7.6. Business performance
- 10.7.7. Key strategic moves and developments
- 10.8. InterVenn Biosciences
- 10.8.1. Company overview
- 10.8.2. Key executives
- 10.8.3. Company snapshot
- 10.8.4. Operating business segments
- 10.8.5. Product portfolio
- 10.8.6. Key strategic moves and developments
- 10.9. Thermo Fisher Scientific, Inc.
- 10.9.1. Company overview
- 10.9.2. Key executives
- 10.9.3. Company snapshot
- 10.9.4. Operating business segments
- 10.9.5. Product portfolio
- 10.9.6. Business performance
- 10.9.7. Key strategic moves and developments
- 10.10. Invitae Corporation
- 10.10.1. Company overview
- 10.10.2. Key executives
- 10.10.3. Company snapshot
- 10.10.4. Operating business segments
- 10.10.5. Product portfolio
- 10.10.6. Business performance
- 10.10.7. Key strategic moves and developments
- 10.11. NeoGenomics Laboratories
- 10.11.1. Company overview
- 10.11.2. Key executives
- 10.11.3. Company snapshot
- 10.11.4. Operating business segments
- 10.11.5. Product portfolio
- 10.11.6. Business performance
- 10.11.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 02. IN VITRO DIAGNOSTICS MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
- TABLE 04. IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 06. IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 07. IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. IN VITRO DIAGNOSTICS MARKET FOR TISSUE DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 10. IN VITRO DIAGNOSTICS MARKET FOR CLINICAL CHEMISTRY, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 13. IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. IN VITRO DIAGNOSTICS MARKET FOR CANCER, BY REGION, 2022-2032 ($MILLION)
- TABLE 15. IN VITRO DIAGNOSTICS MARKET FOR CARDIAC DISEASES, BY REGION, 2022-2032 ($MILLION)
- TABLE 16. IN VITRO DIAGNOSTICS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 17. IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2022-2032 ($MILLION)
- TABLE 18. IN VITRO DIAGNOSTICS MARKET FOR GASTROINTESTINAL DISEASES, BY REGION, 2022-2032 ($MILLION)
- TABLE 19. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 20. GLOBAL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 21. IN VITRO DIAGNOSTICS MARKET FOR STANDALONE LABORATORIES, BY REGION, 2022-2032 ($MILLION)
- TABLE 22. IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 23. IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC AND MEDICAL SCHOOLS, BY REGION, 2022-2032 ($MILLION)
- TABLE 24. IN VITRO DIAGNOSTICS MARKET FOR POINT OF CARE, BY REGION, 2022-2032 ($MILLION)
- TABLE 25. IN VITRO DIAGNOSTICS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 26. IN VITRO DIAGNOSTICS MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 27. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 28. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 29. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 30. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 31. NORTH AMERICA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 32. U.S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 33. U.S. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 34. U.S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 35. U.S. IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 36. CANADA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 37. CANADA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 38. CANADA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 39. CANADA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. MEXICO IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 41. MEXICO IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 42. MEXICO IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 43. MEXICO IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 44. EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 45. EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 46. EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 47. EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 48. EUROPE IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 49. GERMANY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 50. GERMANY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 51. GERMANY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 52. GERMANY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 53. FRANCE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 54. FRANCE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 55. FRANCE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 56. FRANCE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 57. UK IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 58. UK IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 59. UK IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 60. UK IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 61. ITALY IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 62. ITALY IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 63. ITALY IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 64. ITALY IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. SPAIN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 66. SPAIN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 67. SPAIN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 68. SPAIN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 69. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 70. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 71. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 72. REST OF EUROPE IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 73. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 74. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 75. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 76. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 77. ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 78. JAPAN IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 79. JAPAN IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 80. JAPAN IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 81. JAPAN IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 82. CHINA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 83. CHINA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 84. CHINA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 85. CHINA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 86. INDIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 87. INDIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 88. INDIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 89. INDIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 90. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 91. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 92. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 93. AUSTRALIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 94. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 95. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 96. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 97. SOUTH KOREA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 98. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 99. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 100. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 101. REST OF ASIA-PACIFIC IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 102. LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 103. LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 104. LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 105. LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 106. LAMEA IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 107. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 108. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 109. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 110. BRAZIL IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 111. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 112. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 113. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 114. SAUDI ARABIA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 115. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 116. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 117. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 118. SOUTH AFRICA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 119. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022-2032 ($MILLION)
- TABLE 120. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022-2032 ($MILLION)
- TABLE 121. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
- TABLE 122. REST OF LAMEA IN VITRO DIAGNOSTICS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 123. FREENOME HOLDINGS, INC.: KEY EXECUTIVES
- TABLE 124. FREENOME HOLDINGS, INC.: COMPANY SNAPSHOT
- TABLE 125. FREENOME HOLDINGS, INC.: PRODUCT SEGMENTS
- TABLE 126. FREENOME HOLDINGS, INC.: PRODUCT PORTFOLIO
- TABLE 127. FREENOME HOLDINGS, INC.: KEY STRATERGIES
- TABLE 128. NATERA, INC.: KEY EXECUTIVES
- TABLE 129. NATERA, INC.: COMPANY SNAPSHOT
- TABLE 130. NATERA, INC.: PRODUCT SEGMENTS
- TABLE 131. NATERA, INC.: PRODUCT PORTFOLIO
- TABLE 132. NATERA, INC.: KEY STRATERGIES
- TABLE 133. AGILENT TECHNOLOGIES, INC.: KEY EXECUTIVES
- TABLE 134. AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- TABLE 135. AGILENT TECHNOLOGIES, INC.: PRODUCT SEGMENTS
- TABLE 136. AGILENT TECHNOLOGIES, INC.: PRODUCT PORTFOLIO
- TABLE 137. AGILENT TECHNOLOGIES, INC.: KEY STRATERGIES
- TABLE 138. EXACT SCIENCES CORPORATION: KEY EXECUTIVES
- TABLE 139. EXACT SCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 140. EXACT SCIENCES CORPORATION: PRODUCT SEGMENTS
- TABLE 141. EXACT SCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 142. EXACT SCIENCES CORPORATION: KEY STRATERGIES
- TABLE 143. ILLUMINA, INC.: KEY EXECUTIVES
- TABLE 144. ILLUMINA, INC.: COMPANY SNAPSHOT
- TABLE 145. ILLUMINA, INC.: PRODUCT SEGMENTS
- TABLE 146. ILLUMINA, INC.: PRODUCT PORTFOLIO
- TABLE 147. ILLUMINA, INC.: KEY STRATERGIES
- TABLE 148. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 149. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 150. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
- TABLE 151. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 152. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
- TABLE 153. GUARDANT HEALTH: KEY EXECUTIVES
- TABLE 154. GUARDANT HEALTH: COMPANY SNAPSHOT
- TABLE 155. GUARDANT HEALTH: PRODUCT SEGMENTS
- TABLE 156. GUARDANT HEALTH: PRODUCT PORTFOLIO
- TABLE 157. GUARDANT HEALTH: KEY STRATERGIES
- TABLE 158. INTERVENN BIOSCIENCES: KEY EXECUTIVES
- TABLE 159. INTERVENN BIOSCIENCES: COMPANY SNAPSHOT
- TABLE 160. INTERVENN BIOSCIENCES: PRODUCT SEGMENTS
- TABLE 161. INTERVENN BIOSCIENCES: PRODUCT PORTFOLIO
- TABLE 162. INTERVENN BIOSCIENCES: KEY STRATERGIES
- TABLE 163. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
- TABLE 164. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
- TABLE 165. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
- TABLE 166. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
- TABLE 167. THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
- TABLE 168. INVITAE CORPORATION: KEY EXECUTIVES
- TABLE 169. INVITAE CORPORATION: COMPANY SNAPSHOT
- TABLE 170. INVITAE CORPORATION: PRODUCT SEGMENTS
- TABLE 171. INVITAE CORPORATION: PRODUCT PORTFOLIO
- TABLE 172. INVITAE CORPORATION: KEY STRATERGIES
- TABLE 173. NEOGENOMICS LABORATORIES: KEY EXECUTIVES
- TABLE 174. NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT
- TABLE 175. NEOGENOMICS LABORATORIES: SERVICE SEGMENTS
- TABLE 176. NEOGENOMICS LABORATORIES: PRODUCT PORTFOLIO
- TABLE 177. NEOGENOMICS LABORATORIES: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. IN VITRO DIAGNOSTICS MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF IN VITRO DIAGNOSTICS MARKET,2022-2032
- FIGURE 03. TOP IMPACTING FACTORS IN IN VITRO DIAGNOSTICS MARKET
- FIGURE 04. TOP INVESTMENT POCKETS IN IN VITRO DIAGNOSTICS MARKET (2023-2032)
- FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 07. MODERATE THREAT OF SUBSTITUTES
- FIGURE 08. MODERATE INTENSITY OF RIVALRY
- FIGURE 09. HIGH BARGAINING POWER OF BUYERS
- FIGURE 10. GLOBAL IN VITRO DIAGNOSTICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT AND SERVICES, 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR SOFTWARE AND SERVICES, BY COUNTRY 2022 AND 2032(%)
- FIGURE 15. IN VITRO DIAGNOSTICS MARKET, BY TECHNIQUE, 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR HEMATOLOGY, BY COUNTRY 2022 AND 2032(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF IN VITRO DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.